Exceleorqms

Exceleorqms
Stealth ModeAI-powered Quality Management System (QMS) for life sciences, automating compliance and streamlining quality processes.
About
Pricing
View pricing page ↗
What does Exceleorqms do?
ExceleorQMS provides an AI-powered Quality Management System (QMS) specifically designed for the life sciences industry. Their platform automates compliance processes, streamlines quality management, and offers features like multi-standard compliance tracking, gap analysis, audit scheduling, document control, training management, risk assessment, and CAPA management.
What industry does Exceleorqms operate in?
Exceleorqms operates in Quality Management System, Life Sciences Software, Regulatory Compliance, Document Management, Training Management, Deviation Management.
Automates Cyber Resilience Act compliance for connected products in the EU, including SBOM, vulnerability monitoring, and CE technical files.
AI compliance solutions for EU SMEs, focusing on Article 50 transparency.
WERWA is a world-leading RWA (Real-World Asset) tokenization platform that bridges traditional finance and blockchain, offering institutions and asset owners compliant, secure, and efficient solutions.
Market intelligence for East Asia's gaming markets, covering legal frameworks, market entry, and investment opportunities.
AI-powered regulatory document assistant for New Zealand financial institutions.
Bellingbio provides a platform for managing technical records, sample boundaries, review notes, trace points, and repeatable checks.
Governd provides an AI-powered platform for businesses to manage and automate their governance, risk, and compliance (GRC) processes.
Intensive B2C sprints and B2B executive workshops for EU AI Act compliance, with real, on-screen workflows.
An entrant is a company tagged Regulatory Compliance whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.
